Article(id=1326654725048610959, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1326654653699306189, articleNumber=null, orderNo=null, doi=10.13683/j.wph.2025.04.007, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1728662400000, receivedDateStr=2024-10-12, revisedDate=1737820800000, revisedDateStr=2025-01-26, acceptedDate=null, acceptedDateStr=null, onlineDate=1794228734503, onlineDateStr=2026-11-09, pubDate=1744214400000, pubDateStr=2025-04-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1794228734503, onlineIssueDateStr=2026-11-09, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1794228734503, creator=13701087609, updateTime=1794228734503, updator=13701087609, issue=Issue{id=1326654653699306189, tenantId=1146029695717560320, journalId=1319690329412173987, year='2025', volume='46', issue='4', pageStart='315', pageEnd='428', issueExtLink='null', onlineDate='null', pubDate='1744214400000', pubDateStr='2025-04-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1794228717492, creator='13701087609', updateTime=1794273058269, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1326840632833848267, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1326654653699306189, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1326840632838042572, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1326654653699306189, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=362, endPage=366, ext={EN=ArticleExt(id=1326654725237354640, articleId=1326654725048610959, tenantId=1146029695717560320, journalId=1319690329412173987, language=EN, title=Effect of imatinib adjuvant chemotherapy on breast cancer and its influence on FOXA1, GP73 and tumor markers, columnId=1325221089055486019, journalTitle=World Clinical Drug, columnName=Article, runingTitle=null, highlight=null, articleAbstract=
Objective

To investigate the efficacy of imatinib in the treatment of breast cancer and forkhead box protein (FOX)A1, Golgi apparatus protei (GP)73 and tumor markers.

Methods

A total of 100 breast cancer patients treated in Shanghai hospital of traditional Chinese medicine from March 2021 to February 2023 were selected and divided into observation group and control group by simple randomization method, with 50 cases in each group. The control group was treated with paclitaxel combined with carboplatin, and the observation group was treated with imatinib based on the control group. Clinical efficacy, FOXA1, GP73, carcinoembryonic antigen (CEA), carbohydrate antigen (CA)125, CA153, estrogens and the incidence of adverse reactions were compared between the two groups.

Results

After treatment, the total effective rate of observation group was higher than that of control group (90.00% vs. 70.00%, P<0.05). The FOXA1 level in both groups was higher than before treatment, and the observation group was higher than the control group (P<0.05). The levels of GP73, CEA, CA125, CA153, estrone, estradiol and estrogen receptors in both groups were lower than before treatment, and the observation group was lower than the control group (P<0.05). There were no significant differences in the incidence of adverse reactions and complications between the two groups (P>0.05).

Conclusion

Adjuvant chemotherapy of imatinib can improve the levels of FOXA1, GP73 and tumor markers in breast cancer patients, and effectively control the disease.

, authors=Han SUN1, Lihong ZHOU2, Yifei TANG1, *, authorsList=Han SUN, Lihong ZHOU, Yifei TANG, authorCompany=null, correspAuthors=Yifei TANG, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1326654725468041361, articleId=1326654725048610959, tenantId=1146029695717560320, journalId=1319690329412173987, language=CN, title=伊马替尼辅助化疗乳腺癌效果及对FOXA1、GP73及肿瘤标志物的影响分析, columnId=1325221089235841093, journalTitle=世界临床药物, columnName=研究论文, runingTitle=null, highlight=null, articleAbstract=
目的

探讨伊马替尼对乳腺癌的疗效及对叉头框蛋白(forkhead box protein,FOX)A1、高尔基体蛋白(Golgi apparatusprotein,GP)73及肿瘤标志物的影响。

方法

选择2021年3月至2023年2月于上海市中医医院接受治疗的乳腺癌患者100例,以简单排序随机法分为观察组和对照组,每组50例。对照组予紫杉醇联合卡铂治疗,观察组在对照组治疗基础上予伊马替尼治疗。比较两组临床疗效、FOXA1、GP73、癌胚抗原(carcino-embryonic antigen,CEA)、血清糖类抗原(carbohydrate antigen,CA)125、CA153、雌激素水平及不良反应发生情况。

结果

治疗后,观察组总有效率高于对照组(90.00% vs. 70.00%)(P<0.05)。两组FOXA1水平均较前升高,且观察组高于对照组(P<0.05)。两组GP73、CEA、CA125、CA153、雌酮、雌二醇及 雌激素受体水平均较前降低,且观察组低于对照组(P<0.05)。两组不良反应、并发症发生情况无显著差异(P>0.05)。

结论

在乳腺癌患者化疗中辅助使用伊马替尼能保障疗效,帮助改善FOXA1、GP73及肿瘤标记物水平,有效控制病情。

, authors=孙晗1, 周利红2, 汤逸斐1, *, authorsList=孙晗, 周利红, 汤逸斐, authorCompany=null, correspAuthors=汤逸斐, authorNote=

孙晗,主管药师,研究方向:肿瘤防治类药物相关研究。

, correspAuthorsNote=
汤逸斐,副主任药师,研究方向:肿瘤防治类药物相关研究。
, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=9y/av2xBgmNaiwydfdrbDA==, magXml=TrYwsD0fWA8fRGThdEgmbQ==, pdfUrl=null, pdf=dUtZPQzKS7H9+28YadxDUA==, pdfFileSize=978741, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=i1x/YshDbLnGov7B9OT9sQ==, mapNumber=null, fund=null)}, authors=[Author(id=1326654725979746457, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654725048610959, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1326654726084604059, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654725048610959, authorId=1326654725979746457, language=EN, stringName=Han SUN, firstName=Han, middleName=null, lastName=SUN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.Department of Pharmacy, Shanghai Anting Hospital, Shanghai 201805, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1326654726185267356, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654725048610959, authorId=1326654725979746457, language=CN, stringName=孙晗, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.上海安亭医院药剂科,上海 201805, bio={"content":"

孙晗,主管药师,研究方向:肿瘤防治类药物相关研究。

"}, bioImg=null, bioContent=

孙晗,主管药师,研究方向:肿瘤防治类药物相关研究。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1326654725707116690, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654725048610959, xref=1., ext=[AuthorCompanyExt(id=1326654725723893907, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654725048610959, companyId=1326654725707116690, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Department of Pharmacy, Shanghai Anting Hospital, Shanghai 201805, China), AuthorCompanyExt(id=1326654725732282516, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654725048610959, companyId=1326654725707116690, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.上海安亭医院药剂科,上海 201805)])]), Author(id=1326654726243987614, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654725048610959, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1326654726311096480, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654725048610959, authorId=1326654726243987614, language=EN, stringName=Lihong ZHOU, firstName=Lihong, middleName=null, lastName=ZHOU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.Department of Oncology, Shanghai Hospital of Traditional Chinese Medicine, Shanghai 200071, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1326654726386593953, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654725048610959, authorId=1326654726243987614, language=CN, stringName=周利红, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.上海市中医医院肿瘤二科,上海 200071, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1326654725799391381, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654725048610959, xref=2., ext=[AuthorCompanyExt(id=1326654725811974294, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654725048610959, companyId=1326654725799391381, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Department of Oncology, Shanghai Hospital of Traditional Chinese Medicine, Shanghai 200071, China), AuthorCompanyExt(id=1326654725820362903, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654725048610959, companyId=1326654725799391381, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.上海市中医医院肿瘤二科,上海 200071)])]), Author(id=1326654726508228771, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654725048610959, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1326654726613086373, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654725048610959, authorId=1326654726508228771, language=EN, stringName=Yifei TANG, firstName=Yifei, middleName=null, lastName=TANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, *, address=1.Department of Pharmacy, Shanghai Anting Hospital, Shanghai 201805, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1326654726692778150, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654725048610959, authorId=1326654726508228771, language=CN, stringName=汤逸斐, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, *, address=1.上海安亭医院药剂科,上海 201805, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1326654725707116690, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654725048610959, xref=1., ext=[AuthorCompanyExt(id=1326654725723893907, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654725048610959, companyId=1326654725707116690, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Department of Pharmacy, Shanghai Anting Hospital, Shanghai 201805, China), AuthorCompanyExt(id=1326654725732282516, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654725048610959, companyId=1326654725707116690, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.上海安亭医院药剂科,上海 201805)])])], keywords=[Keyword(id=1326654726814412967, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654725048610959, language=EN, orderNo=1, keyword=imatinib), Keyword(id=1326654726923464872, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654725048610959, language=EN, orderNo=2, keyword=breast cancer), Keyword(id=1326654727024128169, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654725048610959, language=EN, orderNo=3, keyword=fractionin), Keyword(id=1326654727112208554, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654725048610959, language=EN, orderNo=4, keyword=golgi protein), Keyword(id=1326654727200288939, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654725048610959, language=EN, orderNo=5, keyword=tumor marker), Keyword(id=1326654727267397804, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654725048610959, language=CN, orderNo=1, keyword=伊马替尼), Keyword(id=1326654727334506669, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654725048610959, language=CN, orderNo=2, keyword=乳腺癌), Keyword(id=1326654727401615534, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654725048610959, language=CN, orderNo=3, keyword=叉头框蛋白), Keyword(id=1326654727464530095, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654725048610959, language=CN, orderNo=4, keyword=高尔基体蛋白), Keyword(id=1326654727535833264, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654725048610959, language=CN, orderNo=5, keyword=肿瘤标志物)], refs=[Reference(id=1326654727661662385, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654725048610959, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=赵灵峰, 林琪. 曲妥珠单抗联合哌柏西利对乳腺癌患者肿瘤标志物和HER2水平的影响[J]. 中国妇幼保健, 2023,38(18): 3439-3442., articleTitle=null, refAbstract=null), Reference(id=1326654727753937074, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654725048610959, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=牛增志, 张玉洁, 张伟. 吡咯替尼联合含紫杉醇化疗方案治疗对晚期HER2阳性乳腺癌患者免疫功能及预后的影响[J]. 实用癌症杂志, 2024, 39(6): 1028-1032., articleTitle=null, refAbstract=null), Reference(id=1326654727821045939, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654725048610959, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=韩艳艳, 是蔷, 杨姗姗. 曲妥珠单抗联合长春瑞滨治疗晚期乳腺癌患者的临床疗效及对生存情况的影响[J]. 癌症进展, 2022, 20(12): 1275-1277., articleTitle=null, refAbstract=null), Reference(id=1326654727888154804, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654725048610959, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=刘蕾, 倪毅, 殷飞. 柴胡疏肝散加减联合CAF方案治疗Ⅲ期乳腺癌的疗效及对血清MMPs、雌激素水平及肿瘤标志物的影响[J]. 中药材, 2020, 43(1): 220-223., articleTitle=null, refAbstract=null), Reference(id=1326654727972040885, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654725048610959, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=JAGSI R, MASON G, OVERMOYER BA, et al.Inflammatory breast cancer defined: proposed common diagnostic criteria to guide treatment and research[J]. Breast Cancer Res Treat, 2022, 192(2): 235-243., articleTitle=null, refAbstract=null), Reference(id=1326654728043344054, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654725048610959, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=李娟, 李晓明, 李平, 等. 格列卫与多西紫杉醇联合对人乳腺癌细胞株MCF-7及其裸鼠移植瘤的作用[J]. 生物技术通讯, 2009, 20(5): 662-665., articleTitle=null, refAbstract=null), Reference(id=1326654728110452919, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654725048610959, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=蔡莹颖. 多西紫杉醇分别联合卡培他滨与卡铂治疗乳腺癌肺转移的疗效比较[J]. 临床合理用药, 2023, 16(5): 134-136., articleTitle=null, refAbstract=null), Reference(id=1326654728181756088, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654725048610959, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=赫捷, 陈万青, 李霓, 等. 中国女性乳腺癌筛查与早诊早治指南(2021, 北京)[J]. 中国肿瘤, 2021, 30(3): 161-191., articleTitle=null, refAbstract=null), Reference(id=1326654728240476345, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654725048610959, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=张婷, 刘起鹏, 郭婉莹, 等. 曲妥珠单抗联合术前新辅助化学治疗对乳腺癌患者肿瘤标志物、血管内皮因子和凋亡因子的影响及疗效观察[J]. 新乡医学院学报, 2020,37(11): 1075-1079., articleTitle=null, refAbstract=null), Reference(id=1326654728315973818, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654725048610959, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=EL MASRI J, PHADKE S. Breast cancer epidemiology and contemporary breast cancer care: a review of the literature and clinical applications[J]. Clin Obstet Gynecol, 2022,65(3): 461-481., articleTitle=null, refAbstract=null), Reference(id=1326654728441802939, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654725048610959, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=郭丽芳, 李敏, 李银英, 等. 卡瑞利珠单抗、阿帕替尼联合卡培他滨二线治疗晚期三阴性乳腺癌的临床研究[J]. 海南医学, 2024, 35(6): 777-781., articleTitle=null, refAbstract=null), Reference(id=1326654728504717500, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654725048610959, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=曹广华. 曲妥珠单抗联合吡咯替尼治疗HER-2阳性晚期乳腺癌的疗效[J]. 医学临床研究, 2023, 40(12): 1989-1991., articleTitle=null, refAbstract=null), Reference(id=1326654728559243453, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654725048610959, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=LEVEY N, KRISHNA I. Breast cancer in pregnancy: caring for the very young breast cancer patient from diagnosis through survivorship[J]. Obstet Gynecol Clin North Am,2022, 49(1): 181-193., articleTitle=null, refAbstract=null), Reference(id=1326654728613769406, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654725048610959, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=吕秀丽, 段小红. 甲磺酸伊马替尼配合VDLD方案诱导治疗儿童急性淋巴细胞白血病的临床疗效[J]. 实用癌症杂志,2021, 36(5): 850-852., articleTitle=null, refAbstract=null), Reference(id=1326654728676683968, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654725048610959, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=冯霞, 肖建, 刘志勇, 等. 表柔比星联合白蛋白紫杉醇治疗对晚期三阴性乳腺癌患者血清BRCA1及FOXA1水平的影响[J]. 临床和实验医学杂志, 2022, 21(5): 508-512., articleTitle=null, refAbstract=null), Reference(id=1326654728756375745, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654725048610959, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=范克锋, 于涛德, 曾响, 等. 乳腺癌患者放疗前后血清高尔基蛋白73表达变化及其临床意义[J]. 中华内分泌外科杂志, 2022, 16(2): 170-173., articleTitle=null, refAbstract=null), Reference(id=1326654728819290307, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654725048610959, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=陆佳团, 王征, 张浩, 等. 乳腺癌患者血清GP73、miR-27a水平的变化及其与临床病理、化疗疗效的相关性[J]. 海南医学, 2024, 35(5): 689-693., articleTitle=null, refAbstract=null), Reference(id=1326654728894787780, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654725048610959, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=夏冰天, 何芳, 宋冰欣, 等. 伊马替尼通过PDGF/PDGFR通路对A549非小细胞肺癌裸鼠移植瘤的抑制作用及机制研究[J]. 肿瘤防治研究, 2023, 50(9): 854-859., articleTitle=null, refAbstract=null), Reference(id=1326654729012228293, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654725048610959, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=李红, 李洋, 曹鸿鑫. 甲磺酸伊马替尼联合VDLD方案治疗小儿急性淋巴细胞白血病的近远期疗效[J]. 癌症进展,2022, 20(16): 1704-1707., articleTitle=null, refAbstract=null), Reference(id=1326654729146446022, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654725048610959, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[20], rfOrder=19, authorNames=null, journalName=null, refType=null, unstructuredReference=王晖, 李艳春, 高秋英, 等. 伊马替尼联合重组人干扰素α-2b治疗加速期慢性髓性白血病患者的疗效及对血清MMP-2、SALL4 mRNA和AGP水平的影响[J]. 中国临床新医学, 2023, 16(5): 468-473., articleTitle=null, refAbstract=null), Reference(id=1326654729217749191, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654725048610959, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[21], rfOrder=20, authorNames=null, journalName=null, refType=null, unstructuredReference=MAASS N, SCHEM C, BAUERSCHLAG DO, et al. Final safety and efficacy analysis of a phase Ⅰ/Ⅱ trial with imatinib and vinorelbine for patients with metastatic breast cancer[J]. Oncology, 2014, 87(5): 300-310., articleTitle=null, refAbstract=null)], funds=null, companyList=[AuthorCompany(id=1326654725707116690, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654725048610959, xref=1., ext=[AuthorCompanyExt(id=1326654725723893907, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654725048610959, companyId=1326654725707116690, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Department of Pharmacy, Shanghai Anting Hospital, Shanghai 201805, China), AuthorCompanyExt(id=1326654725732282516, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654725048610959, companyId=1326654725707116690, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.上海安亭医院药剂科,上海 201805)]), AuthorCompany(id=1326654725799391381, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654725048610959, xref=2., ext=[AuthorCompanyExt(id=1326654725811974294, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654725048610959, companyId=1326654725799391381, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Department of Oncology, Shanghai Hospital of Traditional Chinese Medicine, Shanghai 200071, China), AuthorCompanyExt(id=1326654725820362903, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654725048610959, companyId=1326654725799391381, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.上海市中医医院肿瘤二科,上海 200071)])], figs=null, attaches=null, journal=Journal(id=1319689997550452896, delFlag=0, nameCn=世界临床药物, nameEn=World Clinical Drug, nameHistory1=null, nameHistory2=null, issn=1672-9188, eissn=null, cn=31-1939/R, coden=SLYHAA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=9c6IkcJKa1cF20h1u6lJeQ==, journalPrice=null, startedYear=null, abbrevIsoEn=World Clinical Drug, journalRemark=null, publicationField=null, createdTime=1792568214072, updatedTime=1792747519563, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=S, firstLetterEn=S, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=9c6IkcJKa1cF20h1u6lJeQ==, picEn=MRqUlTwfL6oqIHNy7eyFZQ==, jcr=null, cjcr=null, exts=[JournalExt(id=1320442059660570919, language=CN, name=世界临床药物, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519650, updatedTime=1792747519650, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""}), JournalExt(id=1320442059723485480, language=EN, name=World Clinical Drug, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519665, updatedTime=1792747519665, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""})], databaseList=null, tenantJournalId=1319690329412173987, websiteList=[Website(id=1321427104911179915, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/CN, language=CN, createTime=1792982372739, createBy=18614031015, updateTime=1792982514949, updateBy=18614031015, name=世界临床药物-中文, tplId=1146099689490845704, title=世界临床药物, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428428256031726, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=articleTextType, value=kx, createTime=1792982688249, updateTime=1792982688249, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428193117163, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982688234, updateTime=1792982688234, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428302169073, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=grayFlag, value=0, createTime=1792982688260, updateTime=1792982688260, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428172145642, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982688229, updateTime=1792982688229, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428327334899, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=minRunFlag, value=0, createTime=1792982688266, updateTime=1792982688266, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428226671597, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic, createTime=1792982688242, updateTime=1792982688242, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428314751986, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=silenceFlag, value=0, createTime=1792982688263, updateTime=1792982688263, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428209894380, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982688238, updateTime=1792982688238, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428268614639, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeColor, value=null, createTime=1792982688252, updateTime=1792982688252, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428289586160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982688257, updateTime=1792982688257, creator=18614031015, updator=18614031015)]), Website(id=1321427104990871693, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/EN, language=EN, createTime=1792982372758, createBy=18614031015, updateTime=1792982556355, updateBy=18614031015, name=世界临床药物-英文, tplId=1146101810881728533, title=World Clinical Drug, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428446820021244, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=articleTextType, value=kx, createTime=1792982692675, updateTime=1792982692675, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446757106681, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982692660, updateTime=1792982692660, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447109428223, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=grayFlag, value=0, createTime=1792982692744, updateTime=1792982692744, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446736135160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982692655, updateTime=1792982692655, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447142981632, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=minRunFlag, value=0, createTime=1792982692752, updateTime=1792982692752, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446790661115, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic, createTime=1792982692668, updateTime=1792982692668, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447130399745, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=silenceFlag, value=0, createTime=1792982692749, updateTime=1792982692749, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446769689594, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982692663, updateTime=1792982692663, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446832604157, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeColor, value=null, createTime=1792982692678, updateTime=1792982692678, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447092651006, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982692740, updateTime=1792982692740, creator=18614031015, updator=18614031015)])], journalTitle=世界临床药物, weixinUrl=null, journalUrl=http://www.jwph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=World Clinical Drug, journalPhotoCn=9c6IkcJKa1cF20h1u6lJeQ==, journalPhotoEn=MRqUlTwfL6oqIHNy7eyFZQ==, journalFirstLetter=S, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2025.04.007, detailUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2025.04.007, pdfUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/PDF/10.13683/j.wph.2025.04.007, pdfUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/PDF/10.13683/j.wph.2025.04.007, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1744214400000, fullTextJson=null, articleText=null, reference=null)
收藏切换
伊马替尼辅助化疗乳腺癌效果及对FOXA1、GP73及肿瘤标志物的影响分析
孙晗 1 , 周利红 2 , 汤逸斐 1, *
世界临床药物 | 研究论文 2025,46(4): 362-366
收起
收藏切换
世界临床药物 |研究论文 2025 , 46 (4) : 362 -366
伊马替尼辅助化疗乳腺癌效果及对FOXA1、GP73及肿瘤标志物的影响分析
全屏
[Author(id=1326654725979746457, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654725048610959, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1326654726084604059, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654725048610959, authorId=1326654725979746457, language=EN, stringName=Han SUN, firstName=Han, middleName=null, lastName=SUN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.Department of Pharmacy, Shanghai Anting Hospital, Shanghai 201805, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1326654726185267356, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654725048610959, authorId=1326654725979746457, language=CN, stringName=孙晗, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.上海安亭医院药剂科,上海 201805, bio={"content":"

孙晗,主管药师,研究方向:肿瘤防治类药物相关研究。

"}, bioImg=null, bioContent=

孙晗,主管药师,研究方向:肿瘤防治类药物相关研究。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1326654725707116690, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654725048610959, xref=1., ext=[AuthorCompanyExt(id=1326654725723893907, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654725048610959, companyId=1326654725707116690, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Department of Pharmacy, Shanghai Anting Hospital, Shanghai 201805, China), AuthorCompanyExt(id=1326654725732282516, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654725048610959, companyId=1326654725707116690, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.上海安亭医院药剂科,上海 201805)])]), Author(id=1326654726243987614, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654725048610959, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1326654726311096480, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654725048610959, authorId=1326654726243987614, language=EN, stringName=Lihong ZHOU, firstName=Lihong, middleName=null, lastName=ZHOU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.Department of Oncology, Shanghai Hospital of Traditional Chinese Medicine, Shanghai 200071, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1326654726386593953, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654725048610959, authorId=1326654726243987614, language=CN, stringName=周利红, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.上海市中医医院肿瘤二科,上海 200071, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1326654725799391381, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654725048610959, xref=2., ext=[AuthorCompanyExt(id=1326654725811974294, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654725048610959, companyId=1326654725799391381, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Department of Oncology, Shanghai Hospital of Traditional Chinese Medicine, Shanghai 200071, China), AuthorCompanyExt(id=1326654725820362903, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654725048610959, companyId=1326654725799391381, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.上海市中医医院肿瘤二科,上海 200071)])]), Author(id=1326654726508228771, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654725048610959, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1326654726613086373, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654725048610959, authorId=1326654726508228771, language=EN, stringName=Yifei TANG, firstName=Yifei, middleName=null, lastName=TANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, *, address=1.Department of Pharmacy, Shanghai Anting Hospital, Shanghai 201805, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1326654726692778150, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654725048610959, authorId=1326654726508228771, language=CN, stringName=汤逸斐, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, *, address=1.上海安亭医院药剂科,上海 201805, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1326654725707116690, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654725048610959, xref=1., ext=[AuthorCompanyExt(id=1326654725723893907, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654725048610959, companyId=1326654725707116690, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Department of Pharmacy, Shanghai Anting Hospital, Shanghai 201805, China), AuthorCompanyExt(id=1326654725732282516, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654725048610959, companyId=1326654725707116690, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.上海安亭医院药剂科,上海 201805)])])]
孙晗1, 周利红2, 汤逸斐1, *
作者信息
  • 1.上海安亭医院药剂科,上海 201805
  • 2.上海市中医医院肿瘤二科,上海 200071
通讯作者:
汤逸斐,副主任药师,研究方向:肿瘤防治类药物相关研究。
作者简介:

孙晗,主管药师,研究方向:肿瘤防治类药物相关研究。

Effect of imatinib adjuvant chemotherapy on breast cancer and its influence on FOXA1, GP73 and tumor markers
Han SUN1, Lihong ZHOU2, Yifei TANG1, *
Affiliations
  • 1.Department of Pharmacy, Shanghai Anting Hospital, Shanghai 201805, China
  • 2.Department of Oncology, Shanghai Hospital of Traditional Chinese Medicine, Shanghai 200071, China
出版时间: 2025-04-10 doi: 10.13683/j.wph.2025.04.007
文章导航
收藏切换
目的

探讨伊马替尼对乳腺癌的疗效及对叉头框蛋白(forkhead box protein,FOX)A1、高尔基体蛋白(Golgi apparatusprotein,GP)73及肿瘤标志物的影响。

方法

选择2021年3月至2023年2月于上海市中医医院接受治疗的乳腺癌患者100例,以简单排序随机法分为观察组和对照组,每组50例。对照组予紫杉醇联合卡铂治疗,观察组在对照组治疗基础上予伊马替尼治疗。比较两组临床疗效、FOXA1、GP73、癌胚抗原(carcino-embryonic antigen,CEA)、血清糖类抗原(carbohydrate antigen,CA)125、CA153、雌激素水平及不良反应发生情况。

结果

治疗后,观察组总有效率高于对照组(90.00% vs. 70.00%)(P<0.05)。两组FOXA1水平均较前升高,且观察组高于对照组(P<0.05)。两组GP73、CEA、CA125、CA153、雌酮、雌二醇及 雌激素受体水平均较前降低,且观察组低于对照组(P<0.05)。两组不良反应、并发症发生情况无显著差异(P>0.05)。

结论

在乳腺癌患者化疗中辅助使用伊马替尼能保障疗效,帮助改善FOXA1、GP73及肿瘤标记物水平,有效控制病情。

伊马替尼  /  乳腺癌  /  叉头框蛋白  /  高尔基体蛋白  /  肿瘤标志物
Objective

To investigate the efficacy of imatinib in the treatment of breast cancer and forkhead box protein (FOX)A1, Golgi apparatus protei (GP)73 and tumor markers.

Methods

A total of 100 breast cancer patients treated in Shanghai hospital of traditional Chinese medicine from March 2021 to February 2023 were selected and divided into observation group and control group by simple randomization method, with 50 cases in each group. The control group was treated with paclitaxel combined with carboplatin, and the observation group was treated with imatinib based on the control group. Clinical efficacy, FOXA1, GP73, carcinoembryonic antigen (CEA), carbohydrate antigen (CA)125, CA153, estrogens and the incidence of adverse reactions were compared between the two groups.

Results

After treatment, the total effective rate of observation group was higher than that of control group (90.00% vs. 70.00%, P<0.05). The FOXA1 level in both groups was higher than before treatment, and the observation group was higher than the control group (P<0.05). The levels of GP73, CEA, CA125, CA153, estrone, estradiol and estrogen receptors in both groups were lower than before treatment, and the observation group was lower than the control group (P<0.05). There were no significant differences in the incidence of adverse reactions and complications between the two groups (P>0.05).

Conclusion

Adjuvant chemotherapy of imatinib can improve the levels of FOXA1, GP73 and tumor markers in breast cancer patients, and effectively control the disease.

imatinib  /  breast cancer  /  fractionin  /  golgi protein  /  tumor marker
孙晗, 周利红, 汤逸斐. 伊马替尼辅助化疗乳腺癌效果及对FOXA1、GP73及肿瘤标志物的影响分析. 世界临床药物, 2025 , 46 (4) : 362 -366 . DOI: 10.13683/j.wph.2025.04.007
Han SUN, Lihong ZHOU, Yifei TANG. Effect of imatinib adjuvant chemotherapy on breast cancer and its influence on FOXA1, GP73 and tumor markers[J]. World Clinical Drug, 2025 , 46 (4) : 362 -366 . DOI: 10.13683/j.wph.2025.04.007

参考文献 引证文献
排序方式:
[1]
赵灵峰, 林琪. 曲妥珠单抗联合哌柏西利对乳腺癌患者肿瘤标志物和HER2水平的影响[J]. 中国妇幼保健, 2023,38(18): 3439-3442.
[2]
牛增志, 张玉洁, 张伟. 吡咯替尼联合含紫杉醇化疗方案治疗对晚期HER2阳性乳腺癌患者免疫功能及预后的影响[J]. 实用癌症杂志, 2024, 39(6): 1028-1032.
[3]
韩艳艳, 是蔷, 杨姗姗. 曲妥珠单抗联合长春瑞滨治疗晚期乳腺癌患者的临床疗效及对生存情况的影响[J]. 癌症进展, 2022, 20(12): 1275-1277.
[4]
刘蕾, 倪毅, 殷飞. 柴胡疏肝散加减联合CAF方案治疗Ⅲ期乳腺癌的疗效及对血清MMPs、雌激素水平及肿瘤标志物的影响[J]. 中药材, 2020, 43(1): 220-223.
[5]
JAGSI R, MASON G, OVERMOYER BA, et al.Inflammatory breast cancer defined: proposed common diagnostic criteria to guide treatment and research[J]. Breast Cancer Res Treat, 2022, 192(2): 235-243.
[6]
李娟, 李晓明, 李平, 等. 格列卫与多西紫杉醇联合对人乳腺癌细胞株MCF-7及其裸鼠移植瘤的作用[J]. 生物技术通讯, 2009, 20(5): 662-665.
[7]
蔡莹颖. 多西紫杉醇分别联合卡培他滨与卡铂治疗乳腺癌肺转移的疗效比较[J]. 临床合理用药, 2023, 16(5): 134-136.
[8]
赫捷, 陈万青, 李霓, 等. 中国女性乳腺癌筛查与早诊早治指南(2021, 北京)[J]. 中国肿瘤, 2021, 30(3): 161-191.
[9]
张婷, 刘起鹏, 郭婉莹, 等. 曲妥珠单抗联合术前新辅助化学治疗对乳腺癌患者肿瘤标志物、血管内皮因子和凋亡因子的影响及疗效观察[J]. 新乡医学院学报, 2020,37(11): 1075-1079.
[10]
EL MASRI J, PHADKE S. Breast cancer epidemiology and contemporary breast cancer care: a review of the literature and clinical applications[J]. Clin Obstet Gynecol, 2022,65(3): 461-481.
[11]
郭丽芳, 李敏, 李银英, 等. 卡瑞利珠单抗、阿帕替尼联合卡培他滨二线治疗晚期三阴性乳腺癌的临床研究[J]. 海南医学, 2024, 35(6): 777-781.
[12]
曹广华. 曲妥珠单抗联合吡咯替尼治疗HER-2阳性晚期乳腺癌的疗效[J]. 医学临床研究, 2023, 40(12): 1989-1991.
[13]
LEVEY N, KRISHNA I. Breast cancer in pregnancy: caring for the very young breast cancer patient from diagnosis through survivorship[J]. Obstet Gynecol Clin North Am,2022, 49(1): 181-193.
[14]
吕秀丽, 段小红. 甲磺酸伊马替尼配合VDLD方案诱导治疗儿童急性淋巴细胞白血病的临床疗效[J]. 实用癌症杂志,2021, 36(5): 850-852.
[15]
冯霞, 肖建, 刘志勇, 等. 表柔比星联合白蛋白紫杉醇治疗对晚期三阴性乳腺癌患者血清BRCA1及FOXA1水平的影响[J]. 临床和实验医学杂志, 2022, 21(5): 508-512.
[16]
范克锋, 于涛德, 曾响, 等. 乳腺癌患者放疗前后血清高尔基蛋白73表达变化及其临床意义[J]. 中华内分泌外科杂志, 2022, 16(2): 170-173.
[17]
陆佳团, 王征, 张浩, 等. 乳腺癌患者血清GP73、miR-27a水平的变化及其与临床病理、化疗疗效的相关性[J]. 海南医学, 2024, 35(5): 689-693.
[18]
夏冰天, 何芳, 宋冰欣, 等. 伊马替尼通过PDGF/PDGFR通路对A549非小细胞肺癌裸鼠移植瘤的抑制作用及机制研究[J]. 肿瘤防治研究, 2023, 50(9): 854-859.
[19]
李红, 李洋, 曹鸿鑫. 甲磺酸伊马替尼联合VDLD方案治疗小儿急性淋巴细胞白血病的近远期疗效[J]. 癌症进展,2022, 20(16): 1704-1707.
[20]
王晖, 李艳春, 高秋英, 等. 伊马替尼联合重组人干扰素α-2b治疗加速期慢性髓性白血病患者的疗效及对血清MMP-2、SALL4 mRNA和AGP水平的影响[J]. 中国临床新医学, 2023, 16(5): 468-473.
[21]
MAASS N, SCHEM C, BAUERSCHLAG DO, et al. Final safety and efficacy analysis of a phase Ⅰ/Ⅱ trial with imatinib and vinorelbine for patients with metastatic breast cancer[J]. Oncology, 2014, 87(5): 300-310.
2025年第46卷第4期
68
12
0
引用本文
BibTeX
文章信息
doi: 10.13683/j.wph.2025.04.007
  • 接收时间:2024-10-12
  • 首发时间:2026-11-09
  • 出版时间:2025-04-10
补充材料
相关文章
文章信息
作者
出版历史
  • 收稿日期:2024-10-12
  • 修回日期:2025-01-26
基金
作者信息
    1.上海安亭医院药剂科,上海 201805
    2.上海市中医医院肿瘤二科,上海 200071

通讯作者:

汤逸斐,副主任药师,研究方向:肿瘤防治类药物相关研究。
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2025.04.007
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏